Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 12/20 | 0.41 |
| ▸ | CNR2 | P34972 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MIF | P14174 | 1/20 | 0.31 |
| ▸ | TYR | P14679 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
| ▸ | DRD1 | P21728 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4221162 | 0.90 | ESR2 (0.40) | ESR2CYP2C9ESR1CYP3A4NR1I2 | |
| SCHEMBL4220078 | 0.88 | CNR2 (0.38) | ESR2CNR2 | |
| SCHEMBL3816901 | 0.88 | ALDH1A1 (0.43) | ESR2CYP2C9ESR1NR1I2ALDH1A1 | |
| SCHEMBL2719243 | 0.81 | ESR2 (0.45) | ESR2CYP2C9ESR1CYP3A4 | |
| SCHEMBL503351 | 0.79 | ESR2 (0.44) | ESR2ESR1CYP3A4 | |
| SCHEMBL3808060 | 0.79 | ESR2 (0.43) | ESR2CYP2C9ESR1CYP3A4DRD2 | |
| SCHEMBL2720158 | 0.79 | NR1I2 (0.38) | ESR2CYP2C9ESR1NR1I2ALDH1A1 | |
| SCHEMBL2721633 | 0.78 | ESR2 (0.57) | ESR2CYP2C9ESR1CYP3A4 | |
| SCHEMBL3809669 | 0.78 | ESR2 (0.42) | ESR2CYP2C9ESR1CYP3A4DRD2 | |
| SCHEMBL4218476 | 0.78 | ESR2 (0.47) | ESR2CNR2CYP2C9ESR1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090054669-A1 | Process For Producing Epoxy Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054669-A1 | Process For Producing Epoxy Compound | RER1, AR, CYP1A1 | ESR2 4/4885CNR2 644/4885CYP2C9 669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.